MR编号 | DE/H/2300/001 |
---|
药品名称 | Bilaxten 20 mg Tabletten |
---|
活性成分 | |
---|
剂型 | Tablet |
---|
上市许可持有人 | Menarini International Operations Luxembourg S.A.
1, Avenue de la Gare
1611 Luxembourg
Luxembourg |
---|
参考成员国 - 产品名称 | Germany (DE) Bilaxten 20mg Tabletten |
---|
互认成员国 - 产品名称 | - Denmark (DK)
- Belgium (BE)
- Luxembourg (LU)
- Iceland (IS)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
Nasitop 20 mg Tabletten - France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Poland (PL)
Clatra - Latvia (LV)
Opexa 20 mg tabletes - Lithuania (LT)
Opexa 20 mg tabletės - Estonia (EE)
- Hungary (HU)
LENDIN 20 mg tabletta - Bulgaria (BG)
Fortecal - Cyprus (CY)
BILAZ 20mg TABS - Czechia (CZ)
Depocid 20 mg Tableta - Romania (RO)
BORENAR 20 mg comprimate - Slovakia (SK)
Bilahist 20 mg tablety - Slovenia (SI)
- Malta (MT)
Drynol 20mg tablets
|
---|
许可日期 | 2010/09/08 |
---|
最近更新日期 | 2024/10/25 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:New Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|